Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Catholic University of the Sacred Heart, L.go A. Gemelli 8, 00168 Rome, Italy.
Eur J Surg Oncol. 2012 Dec;38(12):1204-10. doi: 10.1016/j.ejso.2012.08.003. Epub 2012 Aug 28.
To examine the surgical treatment and clinical outcome of elderly and very elderly advanced epithelial ovarian cancer patients.
We retrospectively analyzed FIGO stage IIIC-IV ovarian cancer patients, divided in elderly (Group A, >65 and <75 years) and very elderly patients (Group B, ≥ 75 years) treated by primary debulking surgery (PDS) or by interval debulking surgery (IDS) at the Catholic University at Rome and Campobasso, Italy.
164 patients were included: 123 (Group A) and 41 (Group B). Complete cytoreduction was achieved in 60 patients (60.6%) in Group A and in 20 patients (62.5%) in Group B (p = 0.75). In the remaining cases, optimal cytoreduction was performed (39 cases (39.4%) in Group A and 12 (37.5%) in Group B; p = 0.75). In Group A complete/optimal debulking was achieved in 53 patients (53.5%) at PDS and in 46 patients (46.5%) at IDS (p = 0.55). In the Group B a higher rate of patients was debulked at IDS with respect to PDS (10 (31.3%) vs. 22 patients (68.7%); p = 0.02). In Group A patients debulked at PDS showed better DFS (p = 0.007) and OS (p = 0.003) with respect to patients submitted to successful IDS, whereas in group B we did not observed any survival difference according to time of cytoreduction.
Our data suggest that elderly and very elderly patients may tolerate radical and ultra-radical surgery. These patients should be managed in a gynecologic oncology unit, with prudent but complete approach.
探讨老年和超高龄晚期上皮性卵巢癌患者的手术治疗及临床结局。
我们回顾性分析了国际妇产科联盟(FIGO)分期为 III C-IV 期卵巢癌患者,根据年龄分为老年组(A 组,>65 岁且<75 岁)和超高龄组(B 组,≥75 岁)。A 组接受了初次肿瘤细胞减灭术(PDS),B 组接受了间隔肿瘤细胞减灭术(IDS)。
共纳入 164 例患者,A 组 123 例,B 组 41 例。A 组 60 例(60.6%)和 B 组 20 例(62.5%)达到完全肿瘤细胞减灭(p = 0.75)。其余病例行满意肿瘤细胞减灭术(A 组 39 例,39.4%;B 组 12 例,37.5%;p = 0.75)。A 组中,PDS 组 53 例(53.5%)和 IDS 组 46 例(46.5%)达到完全/满意肿瘤细胞减灭(p = 0.55)。B 组中,IDS 组肿瘤细胞减灭率高于 PDS 组(10 例,31.3%比 22 例,68.7%;p = 0.02)。A 组中,PDS 组患者的无进展生存(DFS)(p = 0.007)和总生存(OS)(p = 0.003)均优于成功接受 IDS 组的患者,而 B 组中,根据肿瘤细胞减灭时间,DFS 和 OS 未见差异。
我们的数据表明,老年和超高龄患者可耐受根治性和超根治性手术。这些患者应在妇科肿瘤学单位进行管理,采用谨慎但完整的方法。